PPARA and metabolic dysfunction-associated steatotic liver disease: A meta-analysis of treatments of patients with NAFLD (for a median duration of 6 months) with supplements of omega 3 fatty acids showed significant ultrasonographic improvement of steatosis, likely involving a reversal of the Srebp-1c/PPARα ratio (Parker et al., 2012).